← Back to Clinical Trials
Recruiting NCT06395974

Fetal Renal Artery Doppler in Patients With Preeclampsia

Trial Parameters

Condition Preeclampsia
Sponsor Assiut University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 88
Sex FEMALE
Min Age N/A
Max Age N/A
Start Date 2023-11-01
Completion 2024-11-01
Interventions
fetal ultrasound

Brief Summary

Preeclampsia is a major devastating disorder affects 2:10% of pregnancies worldwide. preeclampsia may be associated with placental insufficiency which may cause fetal blood redistribution to essential organs like brain, heart, kidney.

Eligibility Criteria

Inclusion Criteria: * a) Preeclampsia: * Women with preeclampsia \>28 weeks of pregnancy. * Singleton pregnancy. * Women with intrauterine growth restriction and abnormal amniotic fluid volume to simulate real world data. b) Control: * Women with healthy pregnancy matched by closest gestational age. Exclusion Criteria: * ● Multiple pregnancy. * Known Congenital fetal malformations. * Women with other comorbidity such as ischemic heart disease, DM, Autoimmune disorders, kidney disease, neurological disorders, liver or haematological disorders. * Women unable to provide informed consent. * Women who refuse to participate

Related Trials